Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03129490 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

Study acronym: DANNOAC-AF
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 38 of 38 sites
    v6
  2. Study sites: 22 to 38v5
  3. Lead sponsor: Danish Heart Foundation to Herlev and Gentofte Hospitalv4 Show 6 more changesShow less
    • Primary and study completion dates: Sep 30, 2021 to Oct 30, 2027
    • Start date: May 1, 2017 to Apr 1, 2023
    • Study sites: 19 to 22
    • Eligibility criteria shortened, about 26 words
    • Study description expanded, about 12 words
    • Collaborators shortened, about 4 words
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 19
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
No randomized head-to-head comparison between the individual Non-vitamin K Antagonist Oral Anticoagulants (NOAC) exists. The DANNOAC-AF study is a nationwide cluster randomized cross-over study comparing efficacy and safety of the four NOACs, edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in atrial fibrillation and atrial flutter across Danish hospitals and cardiology clinics.
Trial Details
NCT Number NCT03129490
Lead Sponsor Herlev and Gentofte Hospital
Conditions
(from sponsor)		 Atrial Fibrillation, Atrial Flutter
Related terms Atrial Fibrillation, Atrial Flutter
Enrollment 11,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov